Jpmorgan Chase & CO Applied Molecular Transport Inc. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.35 - $1.26 $516 - $1,859	-1,476 Reduced 56.53%	1,135 $0
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $1,024 - $2,854	915 Added 53.95%	2,611 $3,000
Q2 2022 Aug 11, 2022	SELL	$2.76 - $7.65 $53,149 - $147,316	-19,257 Reduced 91.91%	1,696 $5,000
Q1 2022 May 11, 2022	BUY	$5.63 - $13.88 $20,673 - $50,967	3,672 Added 21.25%	20,953 $158,000
Q4 2021 Feb 10, 2022	BUY	$13.23 - $26.05 $20,043 - $39,465	1,515 Added 9.61%	17,281 $242,000

Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $407,866 - $734,853	15,766 New	15,766 $408,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.